This EMBO Conference will consider the viruses and virus-like agents associated with a diverse set of microbes that inhabit environments ranging from marine ecosystems to infected human lungs. The conference will focus on the impact these diverse viruses have upon their environment, whether that environment is the human body or a specific niche in the natural environment. The emphasis of the meeting, therefore, will be, ‘Ecological and environmental approaches to studying viruses of microbes’.
This EMBO Conference will include keynote speakers who have pioneered novel approaches to the study of viruses in environmental systems with the view to forging greater synergy between environmental and bacteriophage communities. We believe that this will be of great interest to a wide-ranging audience, for example understanding what constrains and drives diversity will inform those interested in both the fundamental and applied aspects of virus exploitation. Therefore, this meeting is a ‘viruses of microbes’ meeting with the ecology of those viruses at its heart.
We are very pleased to invite you to the 19th Annual Meeting of the European Society for Clinical Virology, that will take place in Lisbon, Portugal, from 14 to 17 September 2016. This meeting will cover hot topics of clinical virology, maintaining the high scientific standards of previous meetings of this Society.
Early Registration: until 22 June 2016
Late Registration: From 22 June 2016
Deadline for abtract submission: 30th May 2016
Chromatin Control of Viral Infection
Natcher Conference Center
NIH, Bethesda, Maryland
Registration and additional information online at: https://www.blsmeetings.net/ViralChromatin2016/
David Knipe (Harvard Medical School); Thomas Kristie (National Institute of Allergy and Infectious Diseases); Alison McBride (National Institute of Allergy and Infectious Diseases); Paul Lieberman (The Wistar Institute); Jonathan Karn (Case Western Reserve University); Meghan Holdorf (Novartis Institutes for BioMedical Research); David Bloom (University of Florida College of Medicine); John Sinclair (University of Cambridge); Ileana Cristea (Princeton University); Alan Engelman (Dana-Farber Cancer Institute, Harvard Medical School); Paul Lehner (Institute for Medical Research, University of Cambridge); Cyprian Rossetto (University of Nevada); Todd Macfarlan (National Institute of Child Health and Development); Sharon Schlesinger (The Hebrew University of Jerusalem); Ivan D’Orso (University of Texas Southwestern Medical Center); Alexander Tarakhovsky (Rockefeller University)
The program will also include select presentations from submitted abstracts as well as poster presentations.
The topic of the IRNCAS International Symposium is the retroviral nucleocapsid protein (NC) and its Gag precursor, a polyprotein responsible for the viral assembly.
This symposium represents an important opportunity in getting together the specialists and generating new collaborations and multidisciplinary studies (biophysics, biochemistry, virology, cellular biology, biomedicine and biophotonics). During the last 15 years, these collaborations have provided important progresses in the insight into the molecular and cellular mechanisms of action of the HIV-1 nucleocapsid and its Gag precursor, making them promising targets in the design of inhibitors against the AIDS epidemics.
This 10th edition should encourage the continuation of our collaborative network in order to enlighten the structural and functional properties of the NC domain of Gag during virus assembly in the host cell.
Special attention will be given to :
- RNA-NC interactions
- Gag and cell factors interactions (membrane lipids and cellular proteins)
- Gag and NC chaperone properties
- The impact of the biophysical methods, notably of the high resolution microscopy and the NMR, on the understanding of Gag assembly
- Therapeutic strategies targeting HIV-1 NC and Gag assembly.
The major topics discussed during this Symposium are focused on the HIV-1 nucleocapsid and on the retroviral Gag proteins, however other nucleocapsid of viruses causing human pathologies (HTLV, Hepatitis and Influenza) will be also considered.
It is my great pleasure to invite you to the 6th European Congress of Virology (ECV) which will take place from October 19-22, 2016 at the Congress Center Hamburg (CCH), Germany.
The European Congress of Virology is the premier virology conference in Europe and is organized by the European Society for Virology (ESV). ECV2016 will bring together both junior and senior scientists, and will cover all aspects of virus research including basic, clinical, veterinary and plant virology.
The Free and Hanseatic City of Hamburg is Germany’s principal port and a centre of maritime and aviation industries, as well as a hub of commerce, media and science. Above all, Hamburg is a city of hospitality and openness, characterized by its extraordinary diversity and tolerance.
The venue of ECV2016, the Congress Center Hamburg (CCH), is located in the city centre, within easy reach of numerous hotels of all categories.
The science, the planned special events, and the city itself will make ECV2016 a highly stimulating and unforgettable international event that should not be missed!
The Chairman and the Latin American correspondent from the Pan American Society for Clinical Virology (PASCV, US), are pleased to invite you to participate at the “IV International Clinical Virology Symposium and Advances in Vaccines” to be held in Buenos Aires, Argentina October 24-26 , 2016.
The main goals for this meeting are to share and discuss knowledge about the advances in viral diagnosis with a main focus in molecular assays and novel technologies, as well as to learn on the improvement, characteristics, and indications of new human vaccines and new therapeutics.
This International Symposium is a great opportunity to gather together colleagues and friends from different countries, exchange knowledge about the recent advances of the most important and frequent issues in Clinical and Diagnostic Virology and advances of new Vaccines.
The workshop aims at providing a platform for sharing knowledge and research advances on human papillomavirus in relation to cancer development, detection, epidemiology & prevention. It will cover a wide range of topics including viral replication & life cycle, functions of oncoproteins, genome & RNA modification & regulation, HPV testing methodology & application, pathogenesis, epidemiology, cancer screening and public health issues. Areas related to cervical, anogenital, oropharyngeal and other cancers possibly associated with HPV are within the scope of this workshop.
- Researchers in the field of tumor virology, especially those focusing on HPV.
- Healthcare providers & administrators who may come across clinical problems related to HPV-associated cancers, especially cervical, anogenital and head & neck cancers.
- Healthcare professionals who may be involved in provision, interpretation or organizing cervical cancer screening programmes.
- Any scientists or clinicians who are interested in updating their knowledge on HPV and HPV-associated cancers.
Kai Chong Tong, G/F, School of Public Health Building,
Prince of Wales Hospital,
Shatin, Hong Kong
Early Registration: 1 March – 15 September 2016
Standard Registration: 16 September – 15 October 2016
Abstract submission: 1 March – 30 June 2016